Rating History for Ligand Pharma (LGND) by BofA Securities

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/27/2026 Jason Zemansky Maintain Buy
(N/A)
260.00
(250.00)
 
 
  Details